Prognostic effect of activated EGFR expression in human colon carcinomas: Comparison with EGFR status

R. L. Rego, N. R. Foster, T. C. Smyrk, M. Le, M. J. O'Connell, D. J. Sargent, H. Windschitl, F. A. Sinicrope

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

Background: Evidence suggests that epidermal growth factor receptor (EGFR)-activation status may better predict the clinical behaviour of colon cancers than does EGFR expression. However, the prognostic effect of phospho-EGFR in primary colon cancer remains undefined.Methods: Phospho-EGFR (Tyr-1173) and EGFR expression were analysed by immunohistochemistry (IHC) in tissue microarrays of TNM stage II and III colon cancers from completed adjuvant therapy trials (n388). Staining intensity was scored and correlated with clinicopathological variables, DNA mismatch repair (MMR) status, rates of cell proliferation (Ki-67), apoptosis (caspase-3), and patient survival.Results: Phospho-EGFR expression was detected in 157 of 388 (40%) tumours, whereas EGFR was found in 214 of 361 (59%). Although phospho-EGFR was unrelated to clinicopathological variables, strong EGFR intensity was associated with higher tumour stage (P0.03). Tumours overexpressing EGFR (P0.0002) or phospho-EGFR (P0.015) showed increased Ki-67, but not caspase-3 expression. Phospho-EGFR was not prognostic. EGFR intensity was associated with worse disease-free survival (DFS) (hazard ratio (HR): 1.21 (1.03, 1.41); P0.019) and overall survival (OS) (HR: 1.19 (1.02, 1.39); P0.028). Tumours expressing both EGFR and phospho-EGFR had similar survival as EGFR alone. Stage and lymph node number were prognostic for DFS and OS, and histological grade for OS. EGFR was an independent predictor of DFS (P0.042) after adjustment for stage, histological grade, age, and MMR status.Conclusion: Phospho-EGFR and EGFR expression were associated with tumour cell hyperproliferation. Phospho-EGFR was not prognostic, whereas increased EGFR intensity was independently associated with poor DFS.

Original languageEnglish (US)
Pages (from-to)165-172
Number of pages8
JournalBritish journal of cancer
Volume102
Issue number1
DOIs
StatePublished - Jan 2010

Keywords

  • Apoptosis
  • Colon cancer
  • EGFR
  • Phosphorylated EGFR
  • Prognosis
  • Proliferation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic effect of activated EGFR expression in human colon carcinomas: Comparison with EGFR status'. Together they form a unique fingerprint.

  • Cite this

    Rego, R. L., Foster, N. R., Smyrk, T. C., Le, M., O'Connell, M. J., Sargent, D. J., Windschitl, H., & Sinicrope, F. A. (2010). Prognostic effect of activated EGFR expression in human colon carcinomas: Comparison with EGFR status. British journal of cancer, 102(1), 165-172. https://doi.org/10.1038/sj.bjc.6605473